Karyopharm Therapeutics
KPTI
KPTI
50 hedge funds and large institutions have $19M invested in Karyopharm Therapeutics in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+3
Holders Change %
+6.38%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
13
Reduced
7
Closed
8
Calls
$1.61M
Puts
$127K
Net Calls
+$1.48M
Net Calls Change
+$995K
Top Buyers
Top Sellers
| 1 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$587K |
| 2 |
Millennium Management
New York
|
-$101K |
| 3 |
SC
Shay Capital
New York
|
-$95.1K |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$88.4K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$43.2K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ACM
51
Altium Capital Management
New York
| – | -$185K | -49,333 | Closed |
|
|
SC
52
Shay Capital
New York
| – | -$95.1K | -25,417 | Closed |
|
|
UOC
53
UBS O'Connor
Chicago,
Illinois
| – | -$88.4K | -23,640 | Closed |
|
|
54
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$43.2K | -11,548 | Closed |
|
55
Jane Street
New York
| – | -$42.7K | -11,420 | Closed |
|
|
CCM
56
Coldstream Capital Management
Bellevue,
Washington
| – | -$1.24K | -331 | Closed |
|
|
QC
57
Quent Capital
New York
| – | -$864 | -231 | Closed |
|
|
VWA
58
VSM Wealth Advisory
Hunt Valley,
Maryland
| – | -$497 | -133 | Closed |
|